India says compulsory license for Nexavar doesn't violate trade pacts

01/31/2013 | Hindu (India), The

India didn't violate multilateral trade agreements by granting a compulsory license for Bayer's cancer treatment Nexavar in order to make it cheaper, Indian Commerce and Industry Minister Anand Sharma told U.S. Economic Growth, Energy and Environment Undersecretary Robert Hormats. An official said that Hormats raised the issue and said patent holders need to know the action will not become routine.

View Full Article in:

Hindu (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL